Business
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment.
About this update from Easton Pharmaceuticals Inc
[{"type":"text","content":"\n \n \n Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment\n \n \nEaston Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment\n \n TORONTO, ON--(Marketwired - Jul 24, 2017) -  Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman's diagnostics and treatment segment products.\n Easton has closed on its agreement with Alliance Group and has acquired 45 acres of agriculturally zoned land north of Toronto to cultivate, produce and facilitate the sale of its production of medical marijuana on a co-managed basis, which would enable and effectively turn Easton into a legalized grower / cultivator and supplier of medical marijuana and soon recreational marijuana for the country of Canada. Easton will advance up to $1.3 million cdn in tranches, with the first tranche already having been advanced on the closing. Easton has received financing commitments for the total funds required and in addition, Easton's investment is protected by a mortgage registered against the property. The property comprises of 45 acres of agricultural land located in the township of Georgina, situated north of Toronto as well as having the right to retain 50% of Alliances aggregate business. Notices have been filed with the appropriate regulatory bodies with approval expected within the next 60 days. Easton is responding to the overwhelming demand for the production of medical marijuana and soon legalized recreational marijuana for the entire country of Canada, with launch expected by the spring of 2018. \n As previously announced, Easton has also closed on its acquisition of revenue producing iBliss Inc., a leading proprietary vaporizer and e-liquids manufacturer based in Toronto Canada possessing a growing list of International sales and clients. Since its closing, the Company has been working diligently negotiating new distribution agreements and strategic relationships. iBliss is on track to deliver revenues which it believes will match its record high of $15,000,000 per year due to new market launches and expansion on new and existing prod...